FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 141 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,646,000 | -26.6% | 350,212 | -4.8% | 0.00% | -33.3% |
| Q2 2020 | $2,244,000 | +290.3% | 367,787 | +45.4% | 0.00% | +200.0% |
| Q1 2020 | $575,000 | -56.2% | 252,897 | -11.6% | 0.00% | -50.0% |
| Q4 2019 | $1,313,000 | +75.8% | 286,096 | +48.5% | 0.00% | +100.0% |
| Q3 2019 | $747,000 | +43.1% | 192,694 | +122.4% | 0.00% | 0.0% |
| Q2 2019 | $522,000 | +161.0% | 86,646 | +479.8% | 0.00% | – |
| Q1 2019 | $200,000 | +42.9% | 14,943 | -0.7% | 0.00% | – |
| Q4 2018 | $140,000 | -41.7% | 15,043 | -0.8% | 0.00% | – |
| Q2 2018 | $240,000 | -50.0% | 15,157 | -30.8% | 0.00% | -100.0% |
| Q4 2017 | $480,000 | -42.7% | 21,913 | +7.2% | 0.00% | 0.0% |
| Q3 2017 | $837,000 | +50.5% | 20,446 | +10.7% | 0.00% | 0.0% |
| Q2 2017 | $556,000 | -22.6% | 18,468 | -7.0% | 0.00% | 0.0% |
| Q1 2017 | $718,000 | -68.3% | 19,861 | -56.1% | 0.00% | -75.0% |
| Q4 2016 | $2,264,000 | -50.9% | 45,192 | -48.6% | 0.00% | -50.0% |
| Q3 2016 | $4,615,000 | +54.6% | 87,915 | +21.8% | 0.01% | +33.3% |
| Q2 2016 | $2,985,000 | -57.7% | 72,199 | -58.5% | 0.01% | -53.8% |
| Q1 2016 | $7,062,000 | -35.3% | 173,823 | -33.9% | 0.01% | -18.8% |
| Q4 2015 | $10,916,000 | +1157.6% | 263,018 | +366.4% | 0.02% | +1500.0% |
| Q3 2015 | $868,000 | -82.8% | 56,390 | -72.2% | 0.00% | -87.5% |
| Q2 2015 | $5,036,000 | -15.0% | 202,759 | -21.8% | 0.01% | -11.1% |
| Q1 2015 | $5,922,000 | +214.5% | 259,149 | +271.6% | 0.01% | +350.0% |
| Q4 2014 | $1,883,000 | – | 69,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|